World Of Taxonomy
61755-056Level 3

LYNOZYFIC (linvoseltamab-gcpt)

**Product type:** Human Prescription Drug

**Active ingredient:** LINVOSELTAMAB

**Strength:** 200 mg/10mL

**Dosage form:** Injection, Solution, Concentrate

**Route:** Intravenous

**Labeler:** Regeneron Pharmaceuticals, Inc.

**Marketing category:** BLA (BLA761400)

GET/api/v1/systems/ndc_fda/nodes/61755-056
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.